SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-043353
Filing Date
2023-04-10
Accepted
2023-04-10 09:00:14
Documents
16
Period of Report
2023-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311339d4_8k.htm   iXBRL 8-K 32166
2 EXHIBIT 1.1 tm2311339d4_ex1-1.htm EX-1.1 279868
3 EXHIBIT 5.1 tm2311339d4_ex5-1.htm EX-5.1 8161
7 GRAPHIC tm2311339d4_ex5-1img001.jpg GRAPHIC 8831
8 GRAPHIC tm2311339d4_ex5-1img002.jpg GRAPHIC 10909
  Complete submission text file 0001104659-23-043353.txt   596432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20230404.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20230404_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20230404_pre.xml EX-101.PRE 22609
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2311339d4_8k_htm.xml XML 3745
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 23809785
SIC: 2834 Pharmaceutical Preparations